Skip to main content
. Author manuscript; available in PMC: 2008 May 21.
Published in final edited form as: Mol Pharmacol. 2007 Dec 21;73(3):1029–1036. doi: 10.1124/mol.107.043869

Table 3.

Plasma pharmacokinetic parameters after i.v. administration of 0.5 or 10 mg/kg midazolam to Cyp3a+/+ and Cyp3a−/− mice.


Midazolam
1′-OH Midazolam
4-OH Midazolam
Cyp3a+/+ Cyp3a−/− Cyp3a+/+ Cyp3a−/− Cyp3a+/+ Cyp3a−/−
0.5 mg/kg
AUC(0−1.5h), hr.μg/L 29.5 ± 2.07 31.1 ± 4.03 29.7 ± 1.62 26.2 ± 3.25 0.95 ± 0.08 1.14 ±0.0
Cl, 1/hr.kg 0.017 ± 0.001 0.016 ± 0.002
10 mg/kg
AUC(0−1.5h), hr.μg/L 842 ± 168 833 ± 111 1849 ± 234 1147 ± 199 * 23.6 ± 5.1 15.8 ± 4
Cl, 1/hr.kg 0.012 ± 0.002 0.012 ± 0.002

AUC(0−1.5h), area under plasma concentration-time curve up to 1.5 hr; Cl, plasma clearance. Data are means ± SD, n = 3−5. * P < 0.05.